Should I buy these 2 exciting penny stocks in November?

I’m looking for the most spectacular cheap UK shares to add to my investment portfolio next month. Here are two I’m paying close attention to.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

British Pennies on a Pound Note

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I love shopping for dirt-cheap UK shares. Here are a couple of top-quality penny stocks I’ve been thinking of buying in November.

A penny stock for the cannabis boom

A flourishing medicinal cannabis market could make Kanabo Group (LSE: KNB) one of the hottest growth shares for this decade. The penny stock manufactures cannabidiol (CBD) oil products as well as the medical-grade VapePod vaporiser. It hopes its cutting-edge vaporiser technology in particular will help it put a dent in the hugely-competitive CBD market and deliver splendid long-term earnings growth.

The news coming out of Kanabo in recent months has been highly encouraging on two fronts. It has signed an accord with Medocann Group to develop new medical products. Meanwhile, Materia Malta (with whom Kanabo agreed to merge with over the summer) received a licence to begin producing cannabis for medicinal and research purposes.

Investors need to remain aware that Kanabo lacks the financial clout of the US heavy-hitters in this fledgling industry. It could therefore be squeezed out of the market as they have more to invest in their products and marketing. Kanabo is also at the pre-revenues stage (excluding a recent small pilot programme), and further share placings could be needed to help it get off the ground.

I’m extremely tempted to buy Kanabo shares right now. But my concerns over the intense competition it will face when it finally gets to market are holding me back. I might ultimately miss the boat. But I think I’ll wait until a clear picture on its early sales performance and the reception of its products emerges before investing my hard-earned cash.

Solar superstar

I’d be much happier to spend out on US Solar Fund (LSE: USFP) this November. As the name suggests, this penny stock invests in solar farms on the other side of the Atlantic. I think it’s therefore on course to capitalise on soaring demand for renewable energy as the climate emergency worsens.

There’s no guarantee that US Solar Fund will generate better shareholder returns that Kanabo, of course. For one, the amount of energy generated by solar panels is obviously highly sensitive to weather patterns. Overcast conditions can have a significant impact on this and, by extension, revenues at solar farm operators. There’s also the fact that operating vast swathes of solar panels is pretty expensive business.

These drawbacks wouldn’t discourage me from investing however. The global solar market is tipped for huge growth over the next decade as fossil fuels fall out of favour. Trends Market Research recently suggested that the global market will be worth $223.3bn by 2026. That compares with a value of $52.5bn in 2018. And the US is one of the friendliest on the planet when it comes to solar policy, putting US Solar Fund in great shape to exploit this opportunity to the fullest.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Will the S&P 500 crash in 2026?

The S&P 500 delivered impressive gains in 2025, but valuations are now running high. Are US stocks stretched to breaking…

Read more »

Teenage boy is walking back from the shop with his grandparent. He is carrying the shopping bag and they are linking arms.
Investing Articles

How much do you need in a SIPP to generate a brilliant second income of £2,000 a month?

Harvey Jones crunches the numbers to show how investors can generate a high and rising passive income from a portfolio…

Read more »

Investing Articles

Will Lloyds shares rise 76% again in 2026?

What needs to go right for Lloyds shares to post another 76% rise? Our Foolish author dives into what might…

Read more »

Investing Articles

How much passive income will I get from investing £10,000 in an ISA for 10 years?

Harvey Jones shows how he plans to boost the amount of passive income he gets when he retires, from FTSE…

Read more »

Investing Articles

Down 34% in 2025 — but could this be one of the UK’s top growth stocks for 2026?

With clarity over research funding on the horizon, could Judges Scientific be one of the UK’s best growth stocks to…

Read more »

piggy bank, searching with binoculars
Investing Articles

Can the rampant Barclays share price beat Lloyds in 2026?

Harvey Jones says the Barclays share price was neck and neck with Lloyds over the last year, and checks out…

Read more »

Investing Articles

Here’s how Rolls-Royce shares could hit £25 in 2026

If Rolls-Royce shares continue their recent performance, then £25 might be on the cards for 2026. Let's take a look…

Read more »

Departure & Arrival sign, representing selling and buying in a portfolio
Investing Articles

Prediction: in 2026 the red-hot Rolls-Royce share price could turn £10,000 into…

Harvey Jones can't believe how rapidlly the Rolls-Royce share price has climbed. Now he looks at the FTSE 100 growth…

Read more »